Albert Xu

Albert Xu

Auto-generated profile, based on publicly available information

Albert Xu

Department of Ophthalmology, University of California, San Francisco, California

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JRJoseph M. Replogle
Joseph M. Replogle
TNThomas M. Norman
Thomas M. Norman
AXAlbert Xu
Albert Xu
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
JCJin Chen
Jin Chen
BABritt Adamson
Britt Adamson

23 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
TNThomas M. Norman
Thomas M. Norman
MHMax A. Horlbeck
Max A. Horlbeck
JRJoseph M. Replogle
Joseph M. Replogle
AGAlex Y. Ge
Alex Y. Ge
AXAlbert Xu
Albert Xu
JWJonathan S. Weissman
Jonathan S. Weissman
Manifold destiny: Mapping of genetic interactions (GIs) is usually based on cell fitness as the phenotypic readout, which obscures the mechanistic origin of interactions. Norman et al. developed a framework for mapping and understanding GIs. This approach leverages high-dimensional single-cell RNA sequencing data gathered from CRISPR-mediated, pooled perturbation screens. Diverse transcriptomic phenotypes construct a “manifold” representing all possible states of the cell. Each perturbation and GI projects the cell state to a particular position on this manifold, enabling unbiased ordering of genes in pathways and systematic classifications of GIs. Science , this issue p. 786

1 August 2018 in Cell
Verified
Journal Article
Closed access
MHMax A. Horlbeck
Max A. Horlbeck
AXAlbert Xu
Albert Xu
MWMin Wang
Min Wang
NBNeal K. Bennett
Neal K. Bennett
CPChong Y. Park
Chong Y. Park
LGLuke A. Gilbert
Luke A. Gilbert

28 June 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LKLuke W. Koblan
Luke W. Koblan
MAMandana Arbab
Mandana Arbab
MSMax W. Shen
Max W. Shen
JHJeffrey A. Hussmann
Jeffrey A. Hussmann
AAAndrew V. Anzalone
Andrew V. Anzalone
DLDavid R. Liu
David R. Liu

1 June 2016 in Developmental Cell
Verified
Journal Article
Closed access
QZQingwei Zhu
Qingwei Zhu
ESErwan Le Scolan
Erwan Le Scolan
NJNadine Jahchan
Nadine Jahchan
XJXiaodan Ji
Xiaodan Ji
AXAlbert Xu
Albert Xu
KLKunxin Luo
Kunxin Luo

1 September 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
QZQingwei Zhu
Qingwei Zhu
ACAmanda Chang
Amanda Chang
AXAlbert Xu
Albert Xu
KLKunxin Luo
Kunxin Luo
Ski-related oncogene SnoN (SnoN or SKIL) regulates multiple signaling pathways in a tissue- and developmental stage–dependent manner and has broad functions in embryonic angiogenesis, mammary gland alveologenesis, cancer, and aging. Here, we report that SnoN also plays a critical role in white adipose tissue (WAT) development by regulating mesenchymal stem cell (MSC) self-renewal and differentiation. We found that SnoN promotes MSC differentiation in the adipocyte lineage by antagonizing activin A/Smad2, but not TGFβ/Smad3 signaling. Mice lacking SnoN or expressing a mutant SnoN defective in binding to the Smads were protected from high-fat diet–induced obesity and insulin resistance, and MSCs lacking a functional SnoN exhibited defective differentiation. We further demonstrated that activin, via Smad2, appears to be the major regulator of WAT development in vivo. We also noted that activin A is abundantly expressed in WAT and adipocytes through an autocrine mechanism and promotes MSC self-renewal and inhibits adipogenic differentiation by inducing expression of the gene encoding the homeobox transcription factor Nanog. Of note, SnoN repressed activin/Smad2 signaling and activin A expression, enabling expression of adipocyte-specific transcription factors and promoting adipogenic differentiation. In conclusion, our study has revealed that SnoN plays an important in vivo role in adipocyte differentiation and WAT development in vivo by decreasing activity in the activin/Smad2 signaling pathway.